This is where world-leading products such as Fragmin (Pfizer), Healon (AMO), Sephadex (Amersham Biosciences), Xylocaine (AstraZeneca) and ReFacto (Wyeth/Biovitrum) originated, all examples of leading biomedical and biotech research performed in an entrepreneurial collaboration between academia and industry.
AnnonsThe Stockholm region Life Science cluster, which is ranked third in Europe, includes companies like AstraZeneca, Pfizer and Biovitrum. AstraZeneca for instance has its largest facility in Södertälje with 8,000 employees. In fact, 12 out of 13 pharmaceutical companies listed in the Fortune 500 have their main Scandinavian sales offices in Stockholm.
AnnonsStem cell research
The cluster also includes six medical universities, including Karolinska Institutet, one of the largest medical universities in Europe with 164 professorial chairs and world leading research in stem cell and other areas. The Karolinska Institute is ranked fourth worldwide among medical universities after Harvard, Cambridge and Oxford.
AnnonsSweden is one of the most advanced nations in Information and Communications Technology, ICT, in the world. The convergence of ICT and medicine creates unique possibilities. Highly competitive business costs, an excellent CRO environment and extensive cooperation between hospitals, universities and companies, are other reasons why the Stockholm region attracts such a large share of Europe’s biomedical investment.
Annons Annons
BREAKING